Department of Ophthalmology, Goethe-University, Frankfurt, Germany.
Department of Ophthalmology, Medical University of Graz, Graz, Austria.
Acta Ophthalmol. 2019 Feb;97(1):e22-e35. doi: 10.1111/aos.13814. Epub 2018 May 31.
To compare results between standard and accelerated corneal collagen cross-linking (CXL) for the treatment of progressive keratoconus.
We performed literature searches in PubMed, Cochrane Library, Web of Science, ISRCTN registry, ClinicalTrials.gov, and EMBASE for studies comparing conventional Dresden (C-CXL) and accelerated CXL (A-CXL). Outcomes were clinical results and changes in corneal properties. Weighted mean differences were used to evaluate the effects.
Here, 22 studies with 1158 eyes (C-CXL: 577 eyes; A-CXL: 581 eyes) were included. At the last follow-up, C-CXL was superior regarding minimum keratometry (p < 0.00001) and demarcation line depth (p < 0.00001), whereas A-CXL should be favoured when considering minimum corneal thickness (p = 0.0005). No differences in uncorrected and corrected distance visual acuity (p = 0.09 and 0.98), spherical equivalent (p = 0.11), spherical and cylindrical error (p = 0.29 and 0.32), maximal and average keratometry (p = 0.05 and 0.65), central corneal thickness (p = 0.15), corneal biomechanical properties (p ≥ 0.21 respectively), time of reepithelialization (p = 0.76), subbasal nerve density (p = 0.69), endothelial cell density (p = 0.30) and morphology (p ≥ 0.40 respectively) were found among both groups.
Consideration of less corneal thinning favours A-CXL, whereas the deeper demarcation line and greater changes in minimum keratometric values in C-CXL may indicate a higher treatment efficacy. Altogether, C-CXL, as well as A-CXL, provides successful results in the strengthening of corneal tissue.
比较标准和加速角膜胶原交联(CXL)治疗进行性圆锥角膜的效果。
我们在 PubMed、Cochrane 图书馆、Web of Science、ISRCTN 注册处、ClinicalTrials.gov 和 EMBASE 中进行了文献检索,以比较传统的德累斯顿(C-CXL)和加速 CXL(A-CXL)。评估的结果为临床结果和角膜特性的变化。使用加权均数差来评估效果。
共纳入 22 项研究,共 1158 只眼(C-CXL:577 只眼;A-CXL:581 只眼)。在最后一次随访时,C-CXL 在最小角膜曲率(p < 0.00001)和分界线深度(p < 0.00001)方面更优,而在考虑最小角膜厚度时,A-CXL 应该更有利(p = 0.0005)。未矫正和矫正的远视力(p = 0.09 和 0.98)、等效球镜(p = 0.11)、球镜和柱镜误差(p = 0.29 和 0.32)、最大和平均角膜曲率(p = 0.05 和 0.65)、中央角膜厚度(p = 0.15)、角膜生物力学特性(p ≥ 0.21)、上皮再植时间(p = 0.76)、基底神经密度(p = 0.69)、内皮细胞密度(p = 0.30)和形态(p ≥ 0.40)在两组之间均无差异。
考虑到角膜变薄较少,A-CXL 更有利,而 C-CXL 的分界线更深,最小角膜曲率值的变化更大,可能表明治疗效果更高。总的来说,C-CXL 和 A-CXL 都能成功增强角膜组织。